Notice of Republication
This article was republished on May 9th, 2014, due to several Supporting Information files being erroneously removed. The publisher apologizes for this error. Please view this article again for all Supporting Information files. The originally published, uncorrected article and the republished, corrected article are provided here for reference.
Supporting Information
Originally published, uncorrected article.
(PDF)
Republished, corrected article.
(PDF)
Reference
- 1. Tóth G, Gardai SJ, Zago W, Bertoncini CW, Cremades N, et al. (2014) Targeting the Intrinsically Disordered Structural Ensemble of α-Synuclein by Small Molecules as a Potential Therapeutic Strategy for Parkinson’s Disease. PLoS ONE 9(2): e87133 doi:10.1371/journal.pone.0087133 [DOI] [PMC free article] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
Supplementary Materials
Originally published, uncorrected article.
(PDF)
Republished, corrected article.
(PDF)
